Envoy Medical (COCH) Total Non-Current Liabilities (2021 - 2026)

Envoy Medical has reported Total Non-Current Liabilities for 6 years, with the latest figure at $19.2 million in Q1 2026.

• Quarterly Total Non-Current Liabilities fell 41.4% year-over-year to $19.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.2 million (down 41.4% YoY) and the FY2025 annual result came in at $20.3 million, down 32.13% from the prior year.
• Total Non-Current Liabilities fell to $19.2 million in Q1 2026 per COCH's latest filing, from $20.3 million in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $38.9 million in Q2 2025 and troughed at $8.1 million in Q4 2023.
• A 5-year average of $21.8 million and a median of $19.9 million in 2023 frame the typical range for Total Non-Current Liabilities.
• The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities slumped 78.97% in 2023, then soared 268.14% in 2024.
• Over 5 years, Total Non-Current Liabilities stood at $38.6 million in 2022, then plunged by 78.97% to $8.1 million in 2023, then jumped by 268.14% to $29.9 million in 2024, then sank by 32.13% to $20.3 million in 2025, then decreased by 5.2% to $19.2 million in 2026.
• According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $19.2 million, $20.3 million, and $15.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.